• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗白细胞介素-10单克隆抗体通过诱导Th1细胞因子和一氧化氮对实验性内脏利什曼病起到保护作用。

Anti-iL-10 mAb protection against experimental visceral leishmaniasis via induction of Th1 cytokines and nitric oxide.

作者信息

Bhattacharjee Surajit, Gupta Gaurav, Bhattacharya Parna, Adhikari Anupam, Majumdar Suchandra Bhattacharya, Majumdar Subrata

出版信息

Indian J Exp Biol. 2009 Jun;47(6):489-97.

PMID:19634715
Abstract

Visceral leishmaniasis is characterized by severe immune suppression of the host. This suppression of the host immune system is primarily mediated by the immunosuppressive cytokine Interleukin-10 (IL-10), whose levels are significantly upregulated during leishmaniasis. This immune suppression is reflected at the level of T-cell dysfunction and abrogation of leishmaniacidal molecules along with a dampened Th1 cytokine response. In the present study, we showed in vivo neutralization of IL-10 by administration of anti IL-10 monoclonal antibodies (mAb) could confer protection against leishmanial pathogenesis. This protective response was primarily mediated by a strong induction of T cell proliferation along with a Th1 biased cytokine response which was further aided by the generation of, leishmanicidal molecules, nitric oxide.

摘要

内脏利什曼病的特征是宿主严重免疫抑制。宿主免疫系统的这种抑制主要由免疫抑制细胞因子白细胞介素-10(IL-10)介导,其水平在利什曼病期间显著上调。这种免疫抑制反映在T细胞功能障碍和利什曼杀菌分子的消除水平上,同时Th1细胞因子反应减弱。在本研究中,我们表明通过给予抗IL-10单克隆抗体(mAb)在体内中和IL-10可以提供针对利什曼病发病机制的保护。这种保护性反应主要由T细胞增殖的强烈诱导以及Th1偏向的细胞因子反应介导,而利什曼杀菌分子一氧化氮的产生进一步促进了这种反应。

相似文献

1
Anti-iL-10 mAb protection against experimental visceral leishmaniasis via induction of Th1 cytokines and nitric oxide.抗白细胞介素-10单克隆抗体通过诱导Th1细胞因子和一氧化氮对实验性内脏利什曼病起到保护作用。
Indian J Exp Biol. 2009 Jun;47(6):489-97.
2
Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.趋化因子在杜氏利什曼原虫感染的BALB/c小鼠中诱导宿主保护性Th1免疫反应
Scand J Immunol. 2007 Dec;66(6):671-83. doi: 10.1111/j.1365-3083.2007.02025.x.
3
A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice.利什曼原虫疫苗脂质体制剂引发的混合Th1/Th2反应可引导易感BALB/c小鼠产生Th1反应并对杜氏利什曼原虫产生抗性。
Vaccine. 2004 Mar 12;22(9-10):1162-71. doi: 10.1016/j.vaccine.2003.09.030.
4
Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection.杜氏利什曼原虫:CD2 偏向性免疫应答使 SAG 介导的治疗偏向于实验感染中的优势 Th1 应答。
Exp Parasitol. 2012 Jul;131(3):274-82. doi: 10.1016/j.exppara.2012.04.007. Epub 2012 May 10.
5
Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.靶向免疫刺激DNA通过上调一氧化氮和激活T细胞治愈实验性内脏利什曼病。
Eur J Immunol. 2003 Jun;33(6):1508-18. doi: 10.1002/eji.200323671.
6
Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response.脂质体中的利什曼原虫抗原通过极化的Th1反应促进保护性免疫并提供针对内脏利什曼病的免疫疗法。
Vaccine. 2007 Aug 29;25(35):6544-56. doi: 10.1016/j.vaccine.2007.05.042. Epub 2007 Jun 8.
7
CXC chemokine-mediated protection against visceral leishmaniasis: involvement of the proinflammatory response.CXC趋化因子介导的针对内脏利什曼病的保护作用:促炎反应的参与
J Infect Dis. 2009 Oct 15;200(8):1300-10. doi: 10.1086/605895.
8
Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.延伸因子-2,杜氏利什曼原虫的 Th1 刺激蛋白,在治愈的利什曼原虫感染患者/仓鼠中产生强烈的 IFN-γ 和 IL-12 反应,并保护仓鼠免受利什曼原虫的挑战。
J Immunol. 2011 Dec 15;187(12):6417-27. doi: 10.4049/jimmunol.1102081. Epub 2011 Nov 11.
9
Induction of cellular and humoral responses by autoclaved and heat-killed antigen of Leishmania donovani in experimental visceral leishmaniasis.在实验性内脏利什曼病中,用经高压灭菌和热灭活的杜氏利什曼原虫抗原诱导细胞和体液免疫反应。
Parasitol Int. 2009 Dec;58(4):359-66. doi: 10.1016/j.parint.2009.07.008. Epub 2009 Jul 26.
10
Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.来自减毒杜氏利什曼原虫前鞭毛体的完全可溶性抗原对实验性内脏利什曼病的完全保护涉及Th1免疫和IL-10的下调。
Eur J Immunol. 2009 Aug;39(8):2146-60. doi: 10.1002/eji.200839017.

引用本文的文献

1
T Lymphocyte Exhaustion During Human and Experimental Visceral Leishmaniasis.人内脏利什曼病和实验性内脏利什曼病中的 T 淋巴细胞耗竭。
Front Immunol. 2022 May 2;13:835711. doi: 10.3389/fimmu.2022.835711. eCollection 2022.
2
EB1-3 Chain of IL-35 Along With TGF-β Synergistically Regulate Anti-leishmanial Immunity.IL-35 的 EB1-3 链与 TGF-β 协同调节抗利什曼原虫免疫。
Front Immunol. 2019 Apr 12;10:616. doi: 10.3389/fimmu.2019.00616. eCollection 2019.
3
Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients.
人类免疫缺陷病毒合并感染患者内脏利什曼病的免疫调节治疗
Front Immunol. 2018 Jan 12;8:1943. doi: 10.3389/fimmu.2017.01943. eCollection 2017.
4
Interleukin-10 and Interferon-γ Levels in Patients with Cutaneous Leishmaniasis Treated with Cryotherapy.冷冻疗法治疗皮肤利什曼病患者的白细胞介素-10和干扰素-γ水平
Iran J Med Sci. 2017 Sep;42(5):488-492.
5
Th1-biased immunomodulation and therapeutic potential of Artemisia annua in murine visceral leishmaniasis.青蒿对小鼠内脏利什曼病的Th1偏向性免疫调节作用及治疗潜力
PLoS Negl Trop Dis. 2015 Jan 8;9(1):e3321. doi: 10.1371/journal.pntd.0003321. eCollection 2015 Jan.
6
Whole blood assay and visceral leishmaniasis: Challenges and promises.全血检测与内脏利什曼病:挑战与前景
Immunobiology. 2014 Apr;219(4):323-8. doi: 10.1016/j.imbio.2014.01.005. Epub 2014 Jan 31.
7
Immunoregulation in human American leishmaniasis: balancing pathology and protection.人类美洲利什曼病中的免疫调节:平衡病理与保护
Parasite Immunol. 2014 Aug;36(8):367-76. doi: 10.1111/pim.12100.
8
Augmentation of antileishmanial efficacy of miltefosine in combination with tuftsin against experimental visceral leishmaniasis.米替福新联合硫肽增强抗内脏利什曼病疗效的实验研究。
Parasitol Res. 2012 Aug;111(2):563-70. doi: 10.1007/s00436-012-2868-z. Epub 2012 Mar 6.